Document Detail


Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy.
MedLine Citation:
PMID:  20494590     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective: Previous regenerative studies have demonstrated massive cell losses after intramyocardial cellular delivery. Therefore, efforts at reducing mechanical losses may prove more successful in optimising cellular therapy. In this study, we hypothesized that escalating mesenchymal stem cells (MSCs) dose will not produce corresponding improvement in cardiac function due to washout of the small cells in microcirculation. Using microspheres similar in size to MSCs, that are encapsulated in alginate-poly-l-lysine-alginate (APA), we tested the hypothesis that size is an important factor in early losses. Methods: In experiment I, five groups of rats (n=9 each) underwent coronary ligation; group I had no treatment; the other groups received escalating 0.5×10(6), 1.5×10(6), 3×10(6) and 5×10(6) of MSCs each. Echocardiogram was performed at baseline, 2 days and 7 weeks after surgery. In experiment II, cell-sized microspheres (10μm) were encapsulated in APA microcapsules. In group I (n=16), rats received bare microspheres, group II (n=16) microspheres within 200μm microcapsules and in group III (n=16), microspheres within 400μm microcapsules. After 20min, hearts were quantified for the amount retained. Results: Myocardial function did not improve further with escalating cell doses beyond an initial response at 1.5×10(6) cells. Encapsulated microspheres in 200μm and 400μm microcapsules demonstrated a fourfold increase in retention rate compared with 10μm microspheres. Conclusion: We concluded that suboptimal functional improvement in this animal model starts at 1.5×10(6) cells and does not respond to escalating cell doses. Improving mechanical retention is possible by increasing the size of the injectate. Microencapsulation could be used to encapsulate donor cells and facilitate functional improvement in cellular heart failure therapy.
Authors:
Adil H Al Kindi; Juan Francisco Asenjo; Yin Ge; Guang Yong Chen; Jasmine Bhathena; Ray C-J Chiu; Satya Prakash; Dominique Shum-Tim
Publication Detail:
Type:  Journal Article     Date:  2010-05-21
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  39     ISSN:  1873-734X     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  241-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Affiliation:
Divisions of Cardiac Surgery and Surgical Research, McGill University Health Center, McGill University, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Iatrogenic transposition of the parotid duct into the maxillary sinus after tooth extraction and clo...
Next Document:  History of post-traumatic stress disorder is associated with impaired neuropsychometric performance ...